Cellectar Biosciences's total assets for Q4 2025 were $14.98M, an increase of 2.40% from the previous quarter. CLRB total liabilities were $5.06M for the fiscal quarter, a -3.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.